Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08754 | 32000567 | Adipocyte | Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. | 2020 | Details |
| A08755 | 32000066 | Biomed Pharmacother | Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. | 2020 | Details |
| A08756 | 31999890 | J Diabetes Investig | Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. | 2020 | Details |
| A08757 | 31999405 | Turk J Med Sci | Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial | 2020 | Details |
| A08758 | 31998789 | Biomed Res Int | Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1. | 2020 | Details |
| A08759 | 31998400 | Evid Based Complement Alternat Med | Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. | 2020 | Details |
| A08760 | 31998283 | Front Immunol | Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. | 2020 | Details |
| A08761 | 31997561 | Liver Int | Collagen biology and non-invasive biomarkers of liver fibrosis. | 2020 | Details |
| A08762 | 31997053 | Dig Dis Sci | Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08763 | 31993314 | Acta Pharm Sin B | Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. | 2019 | Details |
| A08764 | 31993306 | Acta Pharm Sin B | Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications. | 2019 | Details |
| A08765 | 31993304 | Acta Pharm Sin B | Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. | 2019 | Details |
| A08766 | 31993196 | Ann Med Surg (Lond) | Work up of fatty liver by primary care physicians, review. | 2020 | Details |
| A08767 | 31992752 | Sci Rep | Biomarker discovery for chronic liver diseases by multi-omics - a preclinical case study. | 2020 | Details |
| A08768 | 31992372 | Br J Nutr | Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial. | 2020 | Details |
| A08769 | 31991487 | Hepatology | Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study. | 2020 | Details |
| A08770 | 31991386 | Biomed Pharmacother | MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease. | 2020 | Details |
| A08771 | 31991181 | Life Sci | Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08772 | 31990961 | PLoS One | Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. | 2020 | Details |
| A08773 | 31988879 | Pediatr Gastroenterol Hepatol Nutr | Factors associated with Advanced Bone Age in Overweight and Obese Children. | 2020 | Details |
| A08774 | 31988860 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. | 2022 | Details |
| A08775 | 31988589 | World J Gastroenterol | Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. | 2020 | Details |
| A08776 | 31987796 | Gastroenterology | Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08777 | 31987259 | Complement Ther Med | The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2019 | Details |
| A08778 | 31987257 | Complement Ther Med | The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2019 | Details |
| A08779 | 31987120 | Clin Nutr ESPEN | The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. | 2019 | Details |
| A08781 | 31986483 | J Nutr Biochem | Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models. | 2019 | Details |
| A08782 | 31986416 | Biomed Pharmacother | Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis. | 2020 | Details |
| A08783 | 31986085 | Annu Rev Med | Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation. | 2020 | Details |
| A08784 | 31985850 | JPEN J Parenter Enteral Nutr | Identifying Predictors of Response to Vitamin E for the Treatment of Pediatric Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08786 | 31984951 | J Vis Exp | Vinyl Chloride and High-Fat Diet as a Model of Environment and Obesity Interaction. | 2020 | Details |
| A08788 | 31984787 | Am J Physiol Gastrointest Liver Physiol | Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. | 2020 | Details |
| A08789 | 31984635 | Neurogastroenterol Motil | Ghrelin-insulin-like growth factor-1 axis is activated via autonomic neural circuits in the non-alcoholic fatty liver disease. | 2020 | Details |
| A08790 | 31982611 | Clin Gastroenterol Hepatol | Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08791 | 31982488 | Pharmacol Res | Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo. | 2020 | Details |
| A08792 | 31982284 | Eur J Intern Med | The association between education level and chronic liver disease of any etiology. | 2020 | Details |
| A08793 | 31982140 | Biochem Biophys Res Commun | Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK. | 2020 | Details |
| A08794 | 31982006 | Wiad Lek | The role of hydrogen sulfide in the progression of chronic obstructive pulmonary disease in patients with non-alcoholic steatohepatitis | 2019 | Details |
| A08796 | 31981593 | Peptides | The new mechanism of Ghrelin/GHSR-1a on autophagy regulation. | 2020 | Details |
| A08798 | 31981519 | Lancet Gastroenterol Hepatol | The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. | 2020 | Details |
| A08799 | 31981449 | Clin Transl Sci | A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. | 2020 | Details |
| A08800 | 31980746 | Eur J Clin Nutr | Differences in the association of diet quality with body fat distribution between men and women. | 2020 | Details |
| A08801 | 31980690 | Sci Rep | Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08802 | 31980251 | Trends Pharmacol Sci | Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08818 | 31979147 | Nutrients | The Effects of Gelatinized Wheat Starch and High Salt Diet on Gut Microbiota and Metabolic Disorder. | 2020 | Details |
| A08819 | 31979094 | J Clin Med | Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08820 | 31978768 | Biomed Pharmacother | A combination extract of kaffir lime, galangal, and lemongrass maintains blood lipid profiles, hepatocytes, and liver mitochondria in rats with nonalcoholic steatohepatitis. | 2020 | Details |
| A08821 | 31978521 | J Ethnopharmacol | Phenols fragment of Veronica ciliata Fisch. ameliorate free radical-induced nonalcoholic fatty liver disease by mediating PI3K/Akt signaling pathway. | 2020 | Details |
| A08822 | 31978277 | Mol Nutr Food Res | Lipoatrophy-Associated Insulin Resistance and Hepatic Steatosis are Attenuated by Intake of Diet Rich in Omega 3 Fatty Acids. | 2020 | Details |
| A08823 | 31978054 | PLoS One | The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study. | 2020 | Details |
| A08824 | 31976003 | Evid Based Complement Alternat Med | Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXRα) and Pregnane X Receptor (PXR). | 2019 | Details |
| A08825 | 31975453 | J Gastroenterol Hepatol | Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population. | 2020 | Details |
| A08826 | 31975365 | Histol Histopathol | Cathepsin-B dependent autophagy ameliorates steatoheaptitis in chronic exercise rats. | 2020 | Details |
| A08827 | 31975362 | Planta Med | Patchouli Oil Attenuates High Fat Diet-induced Non-alcoholic Hepatic Steatosis. | 2020 | Details |
| A08828 | 31975290 | Eur Radiol Exp | Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH). | 2020 | Details |
| A08829 | 31974594 | Mol Med Rep | Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments. | 2019 | Details |
| A08830 | 31974458 | Sci Rep | Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity. | 2020 | Details |
| A08831 | 31973813 | Biochem Biophys Res Commun | PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice. | 2020 | Details |
| A08832 | 31973214 | Nutrients | Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet. | 2020 | Details |
| A08833 | 31972071 | Cell Physiol Biochem | Integrin Linked Kinase (ILK) Downregulation as an Early Event During the Development of Metabolic Alterations in a Short-Term High Fat Diet Mice Model. | 2020 | Details |
| A08836 | 31969883 | Front Immunol | Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital Microscopy. | 2020 | Details |
| A08837 | 31969822 | Front Pharmacol | Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model. | 2020 | Details |
| A08838 | 31969816 | Front Pharmacol | Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy? | 2020 | Details |
| A08839 | 31969775 | World J Gastroenterol | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. | 2020 | Details |
| A08840 | 31969650 | Sci Rep | Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects. | 2020 | Details |
| A08841 | 31969314 | Pak J Pharm Sci | REVIEW- Contemporary evidence on the dynamic role of probiotics in liver diseases. | 2019 | Details |
| A08842 | 31969089 | Curr Pharm Des | NAFLD at the Interface of the Mother-Infant Dyad. | 2020 | Details |
| A08843 | 31969088 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different? | 2020 | Details |
| A08844 | 31969087 | Curr Pharm Des | Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease. | 2020 | Details |
| A08845 | 31968655 | Nutrients | Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD. | 2020 | Details |
| A08846 | 31968339 | Kidney Blood Press Res | Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study. | 2020 | Details |
| A08847 | 31968197 | Endocr Pract | IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. | 2020 | Details |
| A08848 | 31967400 | Liver Int | Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. | 2019 | Details |
| A08849 | 31966914 | World J Gastrointest Oncol | Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis. | 2020 | Details |
| A08850 | 31966908 | World J Hepatol | Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients. | 2019 | Details |
| A08851 | 31965945 | Curr Drug Discov Technol | Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. | 2021 | Details |
| A08852 | 31965894 | Gut Microbes | Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. | 2020 | Details |
| A08853 | 31965669 | Liver Int | Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos. | 2020 | Details |
| A08854 | 31965579 | Hepatology | Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH. | 2020 | Details |
| A08855 | 31965018 | Sci Rep | Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice. | 2020 | Details |
| A08856 | 31963648 | J Clin Med | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial. | 2020 | Details |
| A08857 | 31963560 | Mar Drugs | Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats. | 2020 | Details |
| A08858 | 31960587 | Liver Int | The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease. | 2020 | Details |
| A08859 | 31960406 | Ann Hum Genet | Inhibition of miR-499-5p expression improves nonalcoholic fatty liver disease. | 2020 | Details |
| A08860 | 31959914 | Cell Death Differ | Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. | 2020 | Details |
| A08863 | 31959521 | Ann Hepatol | NRF-2 and nonalcoholic fatty liver disease. | 2020 | Details |
| A08864 | 31958476 | Diabetes Res Clin Pract | Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. | 2020 | Details |
| A08865 | 31957809 | Biochem J | C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD. | 2020 | Details |
| A08866 | 31957704 | Eur Cytokine Netw | lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. | 2019 | Details |
| A08867 | 31956961 | Diabetes Ther | Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08868 | 31956867 | Food Funct | High fat diet incorporated with meat proteins changes biomarkers of lipid metabolism, antioxidant activities, and the serum metabolomic profile in Glrx1-/- mice. | 2020 | Details |
| A08869 | 31956725 | Contemp Clin Trials Commun | Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study). | 2019 | Details |
| A08870 | 31956330 | Nutr Metab (Lond) | Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study. | 2020 | Details |
| A08871 | 31955626 | Endocr Res | Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice. | 2020 | Details |
| A08872 | 31955491 | Diabetes Metab Res Rev | Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2020 | Details |
| A08873 | 31955065 | Int Immunopharmacol | Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. | 2020 | Details |
| A08874 | 31954687 | Lancet Gastroenterol Hepatol | Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. | 2020 | Details |
| A08875 | 31954491 | J Hepatol | Advances in resection and transplantation for hepatocellular carcinoma. | 2020 | Details |
| A08876 | 31954490 | J Hepatol | Epidemiology and surveillance for hepatocellular carcinoma: New trends. | 2020 | Details |
| A08877 | 31954488 | J Hepatol | Gut microbiome in HCC - Mechanisms, diagnosis and therapy. | 2020 | Details |